Table of Contents
ISRN Pharmacology
Volume 2011 (2011), Article ID 505247, 7 pages
http://dx.doi.org/10.5402/2011/505247
Research Article

Hypolipidemic and Antiobesity-Like Activity of Standardised Extract of Hypericum perforatum L. in Rats

1Pharmacology Research Laboratory, Department of Pharmaceutics, Institute of Technology, Banaras Hindu University, Varanasi 221 005, India
2Pharmacology Research Laboratories, Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany
3Stettiner Straße 1, 76138 Karlsruhe, Germany

Received 31 January 2011; Accepted 13 March 2011

Academic Editor: E. E. El-Fakahany

Copyright © 2011 Gulam Mohammed Husain et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. N. Sastri, The Wealth of India. Vol. V (H-K), The Council of Scientific & Industrial Research, New Delhi, India, 1959.
  2. V. Kumar, P. N. Singh, A. K. Jaiswal, and S. K. Bhattacharya, “Antidepressant activity of Indian Hypericum perforatum Linn in rodents,” Indian Journal of Experimental Biology, vol. 37, no. 12, pp. 1171–1176, 1999. View at Google Scholar · View at Scopus
  3. W. E. Muller, St. John's Wort and Its Active Principles in Depression and Anxiety, Birkhäuser, Basel, Switzerland, 2005.
  4. V. Kumar, P. N. Singh, A. V. Muruganandam, and S. K. Bhattacharya, “Effect of Indian Hypericum perforatum Linn on animal models of cognitive dysfunction,” Journal of Ethnopharmacology, vol. 72, no. 1-2, pp. 119–128, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Kumar, V. K. Khanna, P. K. Seth, P. N. Singh, and S. K. Bhattacharya, “Brain neurotransmitter receptor binding and nootropic studies on Indian Hypericum perforatum Linn,” Phytotherapy Research, vol. 16, no. 3, pp. 210–216, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Kumar, P. N. Singh, and S. K. Bhattacharya, “Neuropsychopharmacological studies on Indian Hypericum perforatum Linn,” in Medicinal and Aromatic Plants-Industrial Profile, Volume: Genus Hypericum, E. Ernst, Ed., pp. 179–226, Taylor & Francis, New York, NY, USA, 1st edition, 2003. View at Google Scholar
  7. V. Kumar, “Potential medicinal plants for CNS disorders: an overview,” Phytotherapy Research, vol. 20, no. 12, pp. 1023–1035, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Serretti and L. Mandelli, “Antidepressants and body weight: a comprehensive review and meta-analysis,” Journal of Clinical Psychiatry, vol. 71, no. 10, pp. 1259–1272, 2010. View at Publisher · View at Google Scholar
  9. M. Kivimäki, M. Hamer, G. D. Batty et al., “Antidepressant medication use, weight gain, and risk of type 2 diabetes: a population-based study,” Diabetes Care, vol. 33, no. 12, pp. 2611–2616, 2010. View at Publisher · View at Google Scholar
  10. M. Menegazzi, M. Novelli, P. Beffy et al., “Protective effects of St. John's wort extract and its component hyperforin against cytokine-induced cytotoxicity in a pancreatic β-cell line,” International Journal of Biochemistry and Cell Biology, vol. 40, no. 8, pp. 1509–1521, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. G. M. Husain, P. N. Singh, and V. Kumar, “Anti-diabetic activity of Indian Hypericum perforatum L. on alloxan-induced diabetic rats,” Pharmacologyonline, vol. 3, pp. 889–894, 2008. View at Google Scholar
  12. G. M. Husain, P. N. Singh, and V. Kumar, “Beneficial effects of a standardised Hypericum perforatum extract in rats with experimentally induced hyperglycemia,” Drug Discoveries and Therapeutics, vol. 3, pp. 215–220, 2009. View at Google Scholar
  13. R. Buettner, J. Schölmerich, and L. C. Bollheimer, “High-fat diets: modeling the metabolic disorders of human obesity in rodents,” Obesity, vol. 15, no. 4, pp. 798–808, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Chang, B. Graham, F. Yakubu, D. Lin, J. C. Peters, and J. O. Hill, “Metabolic differences between obesity-prone and obesity-resistant rats,” American Journal of Physiology, vol. 259, no. 6, pp. R1103–R1110, 1990. View at Google Scholar · View at Scopus
  15. B. E. Levin, A. A. Dunn-Meynell, B. Balkan, and R. E. Keesey, “Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats,” American Journal of Physiology, vol. 273, no. 2, pp. R725–R730, 1997. View at Google Scholar · View at Scopus
  16. R. Jalal, S. M. Bagheri, A. Moghimi, and M. B. Rasuli, “Hypoglycemic effect of aqueous shallot and garlic extracts in rats with fructose-induced insulin resistance,” Journal of Clinical Biochemistry and Nutrition, vol. 41, no. 3, pp. 218–223, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Yadav, S. Jain, and P. R. Sinha, “Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats,” Nutrition, vol. 23, no. 1, pp. 62–68, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. H. G. Vogel, Drug Discovery and Evaluation: Pharmacological Assays, Springer, Berlin, Germany, 2nd edition, 2002.
  19. I. Zavaroni, S. Sander, S. Scott, and G. M. Reaven, “Effect of fructose feeding on insulin secretion and insulin action in the rat,” Metabolism, vol. 29, no. 10, pp. 970–973, 1980. View at Google Scholar · View at Scopus
  20. O. J. Park, D. Cesar, D. Faix, K. Wu, C. H. L. Shackleton, and M. K. Hellerstein, “Mechanisms of fructose-induced hypertriglyceridaemia in the rat. Activation of hepatic pyruvate dehydrogenase through inhibition of pyruvate dehydrogenase kinase,” Biochemical Journal, vol. 282, no. 3, pp. 753–757, 1992. View at Google Scholar · View at Scopus
  21. T. Nakagawa, H. Hu, S. Zharikov et al., “A causal role for uric acid in fructose-induced metabolic syndrome,” American Journal of Physiology, vol. 290, no. 3, pp. F625–F631, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar · View at Scopus
  23. K. Srinivasan, B. Viswanad, L. Asrat, C. L. Kaul, and P. Ramarao, “Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening,” Pharmacological Research, vol. 52, no. 4, pp. 313–320, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. L. K. Han, Y. Kimura, and H. Okuda, “Anti-obesity effects of natural products,” in Studies in Natural Products Chemistry, Atta-ur-Rahman, Ed., vol. 30, pp. 79–110, 2005. View at Google Scholar
  25. E. Ikonen, “Mechanisms for cellular cholesterol transport: defects and human disease,” Physiological Reviews, vol. 86, no. 4, pp. 1237–1261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Laggner, S. Schreier, M. Hermann et al., “The main components of St John's Wort inhibit low-density lipoprotein atherogenic modification: a beneficial “side effect” of an OTC antidepressant drug?” Free Radical Research, vol. 41, no. 2, pp. 234–241, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. H. P. Chudasama and P. A. Bhatt, “Evaluation of anti-obesity activity of duloxetine in comparison with sibutramine along with its anti-depressant activity: an experimental study in obese rats,” Canadian Journal of Physiology and Pharmacology, vol. 87, no. 11, pp. 900–907, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. S. H. Hsiao, H. H. Chung, Y. C. Tong, and J. T. Cheng, “Chronic fluoxetine administration desensitizes the hyperglycemia but not the anorexia induced by serotonin in rats receiving fructose-enriched chow,” Neuroscience Letters, vol. 404, no. 1-2, pp. 6–8, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. W. E. Müller, “Effects of hypericum extract (Ll 160) in biochemical models of antidepressant activity,” Pharmacopsychiatry, vol. 30, supplement 2, pp. 102–107, 1997. View at Google Scholar
  30. A. G. Brasswell and A. J. Ahmed, “Method for controlling weight with Hypericum perforatum and Garcinia cambogia,” US patent no. 5911992, 1999.
  31. I. Yegorova and D. Jiang, “Compositions and methods for regulating metabolism and balancing body weight,” US patent no. 6399089, 2002.